These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18729535)

  • 1. Short- versus long-course antibacterial therapy for community-acquired pneumonia : a meta-analysis.
    Dimopoulos G; Matthaiou DK; Karageorgopoulos DE; Grammatikos AP; Athanassa Z; Falagas ME
    Drugs; 2008; 68(13):1841-54. PubMed ID: 18729535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients.
    López-Alcalde J; Rodriguez-Barrientos R; Redondo-Sánchez J; Muñoz-Gutiérrez J; Molero García JM; Rodríguez-Fernández C; Heras-Mosteiro J; Marin-Cañada J; Casanova-Colominas J; Azcoaga-Lorenzo A; Hernandez Santiago V; Gómez-García M
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD009070. PubMed ID: 30188565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.
    Lode H; File TM; Mandell L; Ball P; Pypstra R; Thomas M;
    Clin Ther; 2002 Nov; 24(11):1915-36. PubMed ID: 12501883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shorter versus longer duration of Amoxicillin-based treatment for pediatric patients with community-acquired pneumonia: a systematic review and meta-analysis.
    R Marques I; P Calvi I; A Cruz S; M F Sanchez L; F Baroni I; Oommen C; H Padrao EM; C Mari P
    Eur J Pediatr; 2022 Nov; 181(11):3795-3804. PubMed ID: 36066660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-course vs long-course antibiotic treatment for community-acquired pneumonia: A literature review.
    Møller Gundersen K; Nygaard Jensen J; Bjerrum L; Hansen MP
    Basic Clin Pharmacol Toxicol; 2019 May; 124(5):550-559. PubMed ID: 30694600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months.
    Haider BA; Saeed MA; Bhutta ZA
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005976. PubMed ID: 18425930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: a meta-analysis of randomized trials.
    Falagas ME; Karageorgopoulos DE; Grammatikos AP; Matthaiou DK
    Br J Clin Pharmacol; 2009 Feb; 67(2):161-71. PubMed ID: 19154447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- versus long-course antibiotic therapy for acute pyelonephritis in adolescents and adults: a meta-analysis of randomized controlled trials.
    Kyriakidou KG; Rafailidis P; Matthaiou DK; Athanasiou S; Falagas ME
    Clin Ther; 2008 Oct; 30(10):1859-68. PubMed ID: 19014841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin.
    Léophonte P; File T; Feldman C
    Respir Med; 2004 Aug; 98(8):708-20. PubMed ID: 15303634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial.
    Bielicki JA; Stöhr W; Barratt S; Dunn D; Naufal N; Roland D; Sturgeon K; Finn A; Rodriguez-Ruiz JP; Malhotra-Kumar S; Powell C; Faust SN; Alcock AE; Hall D; Robinson G; Hawcutt DB; Lyttle MD; Gibb DM; Sharland M;
    JAMA; 2021 Nov; 326(17):1713-1724. PubMed ID: 34726708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.
    File TM; Mandell LA; Tillotson G; Kostov K; Georgiev O
    J Antimicrob Chemother; 2007 Jul; 60(1):112-20. PubMed ID: 17537866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trials.
    Zhang L; Wang R; Falagas ME; Chen LA; Liu YN
    Chin Med J (Engl); 2012 Feb; 125(4):687-95. PubMed ID: 22490497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months.
    Lassi ZS; Imdad A; Bhutta ZA
    Cochrane Database Syst Rev; 2015 Jun; (6):CD008032. PubMed ID: 26077639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children.
    Karageorgopoulos DE; Valkimadi PE; Kapaskelis A; Rafailidis PI; Falagas ME
    Arch Dis Child; 2009 Aug; 94(8):607-14. PubMed ID: 19628879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review and Meta-analysis of the Efficacy of Short-Course Antibiotic Treatments for Community-Acquired Pneumonia in Adults.
    Tansarli GS; Mylonakis E
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age.
    Lassi ZS; Das JK; Haider SW; Salam RA; Qazi SA; Bhutta ZA
    Arch Dis Child; 2014 Jul; 99(7):687-93. PubMed ID: 24431417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT).
    Lyttle MD; Bielicki JA; Barratt S; Dunn D; Finn A; Harper L; Jackson P; Powell CVE; Roland D; Stohr W; Sturgeon K; Wan M; Little P; Faust SN; Robotham J; Hay AD; Gibb DM; Sharland M;
    BMJ Open; 2019 May; 9(5):e029875. PubMed ID: 31123008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of hospitalization rates in patients with community-acquired pneumonia treated with 10 days of telithromycin or clarithromycin.
    Niederman MS; Chang JR; Stewart J; Nusrat R; Nieman RB
    Curr Med Res Opin; 2004 May; 20(5):749-56. PubMed ID: 15140342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial.
    Pernica J; Harman S; Kam A; Bailey J; Carciumaru R; Khan S; Fulford M; Thabane L; Slinger R; Main C; Smieja M; Loeb M
    Trials; 2018 Feb; 19(1):83. PubMed ID: 29391051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.